Harvard Bioscience, Inc.: Harvard Bioscience Announces First Quarter 2023 Financial Results
Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4 million